CEOP/IVE/GDP alternating regimen compared with CEOP as the first-line therapy for newly diagnosed patients with peripheral T cell lymphoma: results from a phase 2, multicenter, randomized, controlled clinical trial

Cai, Ming-Ci; Cheng, Shu; Wang, Xin; Hu, Jian-Da; Song, Yong-Ping; Huang, Yao-Hui; Yan, Zi-Xun; Jiang, Yu-Jie; Fang, Xiao-Sheng; Zheng, Xiao-Yun; Dong, Li-Hua; Ji, Meng-Meng; Wang, Li; Xu, Peng-Peng; Zhao, Wei-Li

期刊名称Genome Medicine
作者Cai, Ming-Ci; Cheng, Shu; Wang, Xin; Hu, Jian-Da; Song, Yong-Ping; Huang, Yao-Hui; Yan, Zi-Xun; Jiang, Yu-Jie; Fang, Xiao-Sheng; Zheng, Xiao-Yun; Dong, Li-Hua; Ji, Meng-Meng; Wang, Li; Xu, Peng-Peng; Zhao, Wei-Li
卷第12卷
期第1期
电子ISSN1756-994X
文件大小1875.63KB
发表时间2020-12
DOI10.1186/s13073-020-00739-0

发现好书期刊，享受阅读乐趣

CEOP/IVE/GDP alternating regimen compared with CEOP as the first-line therapy for newly diagnosed patients with peripheral T cell lymphoma: results from a phase 2, multicenter, randomized, controlled clinical trial